D-687-2013 Class II Terminated

Recalled by Sun Pharmaceutical Industries Inc. — Cranbury, NJ

FDA drug recall D-687-2013 was initiated by Sun Pharmaceutical Industries Inc. on May 21, 2013 and is designated Class II. Reason for recall: Crystallization; crystallized nimodipine The recall status is terminated (terminated Aug 25, 2014). Affected quantity: 46387 Cartons.

Recall details

Product Type
Drugs
Report Date
Jul 17, 2013
Initiation Date
May 21, 2013
Termination Date
Aug 25, 2014
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
46387 Cartons

Product description

Nimodipine Capsules 30 mg, Rx Only, For Institutional Use Only, a) 30-count unit dose Capsules (5x6 blister cards per carton), NDC 57664-135-64, b) 100-count unit dose Capsules (25x4 blister cards per carton), NDC 57664-135-65, Distributed by: Caraco Pharmaceutical Laboratories, Ltd. Detroit, MI 48202 Affiliate of Sun Pharmaceutical Industries, Inc.

Reason for recall

Crystallization; crystallized nimodipine

Distribution pattern

Nationwide and Puerto Rico

Code information

Lot #s: a) 3305.036B, 3305.037B, Exp Jun-13; 3505.041B, Exp Sep-13; 3305.043B, Exp Nov-13; 3305.044B, Exp Dec-13; 3305.045B Mar-14. Lot #s: b) 3305.036A, 3305.037A, Exp Jun-13; 3305.038A, Exp Jul-13; 3305.040A, 3505.041A Exp Sep-13; 3305.042A, 3305.043A, Exp Nov-13; 3305.044A Dec-13.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-687-2013
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-687-2013. Report a data issue: hello@regdatalab.com.